Jewish news.Torah perspective.Tzniut-safe. Hourly.
GuruVox — we handle your social media

Sponsored placementAdvertise on KolBinah

Write for us
Scienceisraelhayom

Not Just Weight Loss: The Surprising Link Between Weight-Loss Drugs and Dementia

A large-scale Israeli study conducted among approximately 47,000 Clalit patients found that the use of GLP-1 class drugs, including Ozempic and Saxenda, was associated with a 14% reduction in the risk of developing dementia. Among…

— israelhayom

Assessment

A large Israeli study of 47,000 Clalit patients found that GLP-1 drugs like Ozempic and Saxenda are linked to a 14 percent lower risk of dementia. The protective association was stronger in women (22 percent) and people over 65 (18 percent). The researchers are careful to say this is not yet proof of cause and effect. The finding adds a potential neurological benefit to a class of drugs already known for weight loss and cardiovascular effects, which could reshape how doctors weigh their use.

Read full article at israelhayom →